Assessment of myopic rebound effect after discontinuation of treatment with 0.01% atropine eye drops in Japanese school-age children-Reference-Cited by-同舟云学术

Assessment of myopic rebound effect after discontinuation of treatment with 0.01% atropine eye drops in Japanese school-age children

Published:2023-08-07 Issue:5 Volume:67 Page:602-611
ISSN:0021-5155
Container-title:Japanese Journal of Ophthalmology
language:en
Short-container-title:Jpn J Ophthalmol

Author:

Hieda Osamu,Hiraoka Takahiro,Fujikado Takashi,Ishiko Satoshi,Hasebe Satoshi,Torii Hidemasa,Takahashi Hiroshi,Tanaka Shiro,Kinoshita Shigeru,Nakamura Yo,Sotozono Chie,Oshika Tetsuro,Morimoto Takeshi,Nishida Kohji,Nishikawa Noriko,Song Young-Seok,Tokutake Tomoki,Nishi Yasuyo,Shigeno Yuta,Kurihara Toshihide,Negishi Kazuno,Tsubota Kazuo,Ono Masafumi,Nakai Tomoko,Tan Donald,

Funder

Eye-Lens Pte., Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10384-023-01012-8.pdf

Reference29 articles.

1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–42.

2. Xie Z, Long Y, Wang J, Li Q, Zhang Q. Prevalence of myopia and associated risk factors among primary students in Chongqing: multilevel modeling. BMC Ophthalmol. 2020;20:146.

3. Bullimore MA, Brennan NA. Myopia control: why each diopter matters. Optom Vis Sci. 2019;96:463–5.

4. Bullimore MA, Ritchey ER, Shah S, Leveziel N, Bourne RRA, Flitcroft DI. The risks and benefits of myopia control. Ophthalmology. 2021;128:1561–79.

5. Wang WY, Chen C, Chang J, Chien L, Shih YF, Lin LLK, et al. Pharmacotherapeutic candidates for myopia: a review. Biomed Pharmacother. 2021;133: 111092.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia – Atropine for the Treatment of Myopia (WA‐ATOM) study;Clinical & Experimental Ophthalmology;2024-02-23

2. Myopia progression after cessation of atropine in children: a systematic review and meta-analysis;Frontiers in Pharmacology;2024-01-22